COVID-19 Saliva Screening Test Potential Market Estimated At USD 3,406.2 Billion By 2023
San Francisco, 21 June 2021: The Report COVID-19 Saliva Screening Test Potential Market Size, Share & Trends Analysis Report By Location (Travel Stations), By Technology, By Mode (Centralized Testing, Decentralized Testing), By Region, And Segment Forecasts, 2021 - 2023 The global COVID-19 saliva screening test potential market size is expected to reach USD 3,406.2 billion by 2023, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 4.8% from 2021 to 2023. The rise in demand for rapid, efficient, saliva-based screening tests has positively impacted market growth. This is primarily due to the various advantages offered by saliva-based tests, increasing product approvals by regulatory bodies, and a paradigm shift toward point-of-care testing. The fluorescence-labeled antigen/antibodies test is one of the recent saliva-based COVID-19 screening tests in the market which is based on the principles of fluorescence detection, biochem